Research statistics
Liraglutide research: publications and trials
At a glance
Publications, all years
4,873
Since 2001
Publications in 2026 so far
477
Through November 15, 2026
Human clinical research
35.9%
1,743 of 4,853 classified
Registered clinical trials
457
ClinicalTrials.gov
Randomized controlled trials
648
Publications reporting an RCT in people
Systematic reviews and meta-analyses
406
Preclinical studies
29.7%
1,131 animal · 212 in vitro · 100 computational
Records that only mention it
812
Not counted above
Status in the library: FDA-approved. Groups: GLP-1 receptor agonists. 20 publications are not yet classified by study type.
What to keep in mind
- Some completed trials have neither posted results nor a linked results publication.
Publications by year
Liraglutide publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 2001 | 0 | 2 | 0 | 0 | 2 |
| 2002 | 3 | 2 | 0 | 0 | 5 |
| 2003 | 2 | 2 | 1 | 0 | 5 |
| 2004 | 3 | 0 | 5 | 0 | 8 |
| 2005 | 1 | 1 | 6 | 1 | 9 |
| 2006 | 2 | 1 | 3 | 3 | 9 |
| 2007 | 2 | 4 | 17 | 1 | 24 |
| 2008 | 7 | 3 | 14 | 1 | 25 |
| 2009 | 12 | 10 | 29 | 7 | 58 |
| 2010 | 17 | 6 | 52 | 17 | 92 |
| 2011 | 35 | 18 | 57 | 9 | 119 |
| 2012 | 39 | 30 | 51 | 13 | 133 |
| 2013 | 54 | 36 | 38 | 12 | 140 |
| 2014 | 80 | 64 | 41 | 11 | 196 |
| 2015 | 101 | 75 | 55 | 29 | 260 |
| 2016 | 100 | 65 | 76 | 40 | 281 |
| 2017 | 104 | 76 | 72 | 40 | 292 |
| 2018 | 101 | 106 | 80 | 14 | 301 |
| 2019 | 114 | 129 | 48 | 35 | 326 |
| 2020 | 112 | 122 | 52 | 20 | 306 |
| 2021 | 117 | 114 | 73 | 14 | 318 |
| 2022 | 113 | 98 | 55 | 19 | 285 |
| 2023 | 124 | 102 | 68 | 13 | 307 |
| 2024 | 168 | 119 | 107 | 18 | 412 |
| 2025 | 162 | 140 | 155 | 26 | 483 |
| 2026 (to date) | 170 | 118 | 172 | 17 | 477 |
Study types
| Animal study | 1,131 |
|---|---|
| Review | 921 |
| Observational human study | 731 |
| Randomized controlled trial | 648 |
| Editorial, letter or other | 328 |
| Meta-analysis | 234 |
| In vitro study | 212 |
| Case report | 185 |
| Other clinical trial | 179 |
| Systematic review | 172 |
| Computational study | 100 |
| Not yet classified | 20 |
| Guideline or consensus | 12 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Metabolic health | 3,742 |
|---|---|
| Endocrinology | 2,534 |
| Obesity and weight management | 1,429 |
| Cardiovascular | 819 |
| Neurological and mental health | 535 |
| Gastrointestinal | 474 |
| Immune system | 290 |
| Reproductive and sexual health | 244 |
| Cognitive health | 152 |
| Oncology | 141 |
| Musculoskeletal | 130 |
| Tissue repair | 84 |
Registered clinical trials
101 of 339 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.
Completed: 343 · Unknown status: 54 · Terminated: 20 · Withdrawn: 14 · Recruiting: 13 · Active, not recruiting: 9 · Not yet recruiting: 2 · Enrolling by invitation: 1 · Suspended: 1
Early phase 1: 5 · Phase not applicable: 88 · Phase 1: 64 · Phase 1 / Phase 2: 6 · Phase 2: 60 · Phase 2 / Phase 3: 6 · Phase 3: 106 · Phase 4: 122
The 50 most recently started of 457 trials.
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- Efficacy and safety of GLP-1 receptor agonists for antipsychotic-related overweight and metabolic dysregulation: a systematic review and meta-analysis.
European journal of clinical pharmacology · October 24, 2026 · Meta-analysis · cited 0 times
PMID 42920001 · DOI 10.1007/s00228-026-04206-4 · Reviews and meta-analyses
- GLP-1 receptor agonists for obstructive sleep apnea: a meta-analysis of randomized controlled trials.
Sleep & breathing = Schlaf & Atmung · October 6, 2026 · Meta-analysis · cited 0 times
PMID 42837024 · DOI 10.1007/s11325-026-03826-5 · Reviews and meta-analyses
- Comparative Risk of Nonarteritic Anterior Ischemic Optic Neuropathy Among Glucagon-Like Peptide-1 Receptor Agonists: An Integrated Safety and Mechanistic Analysis.
Diabetes, obesity & metabolism · September 21, 2026 · Meta-analysis · cited 0 times · open access
PMID 42768849 · DOI 10.1111/dom.71358 · Reviews and meta-analyses
- Glucagon-like receptor-1 agonists and impotence: A meta-analysis.
World journal of methodology · September 20, 2026 · Meta-analysis · cited 0 times · open access
PMID 42626264 · DOI 10.5662/wjm.119385 · Reviews and meta-analyses
- GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis.
Drugs · September 12, 2026 · Meta-analysis · cited 1 times · open access
PMID 42730869 · DOI 10.1007/s40265-026-02365-3 · Reviews and meta-analyses
- Weight regain following discontinuation of glucagon-like peptide-1 receptor agonists in adults who are overweight or obese: a systematic review and meta-analysis.
PeerJ · September 8, 2026 · Meta-analysis · cited 0 times · open access
PMID 42729958 · DOI 10.7717/peerj.21713 · Reviews and meta-analyses
- Use of incretin receptor agonists in patients submitted to metabolic bariatric surgery - a systematic review and meta-analysis.
Frontiers in endocrinology · August 26, 2026 · Meta-analysis · cited 0 times · open access
PMID 42718598 · DOI 10.3389/fendo.2026.1870008 · Reviews and meta-analyses
- Safety and Efficacy of Glucagon Like Peptide-1 Receptor Agonism-Based Therapies in End-Stage Renal Disease: A Systematic Review and Meta-Analysis.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · August 4, 2026 · Meta-analysis · cited 0 times
PMID 42551699 · DOI 10.1016/j.eprac.2026.07.018 · Reviews and meta-analyses
- Hypertensive disorders of pregnancy and GLP-1 receptor agonist timing: a systematic review and meta-analysis.
Endocrine · July 31, 2026 · Meta-analysis · cited 0 times · open access
PMID 42536323 · DOI 10.1007/s12020-026-04701-9 · Reviews and meta-analyses
- Effects of glucagon-like peptide-1 receptor agonists on metabolic outcomes in antipsychotic-treated patients with schizophrenia: A systematic review and meta-analysis.
Schizophrenia research · July 24, 2026 · Meta-analysis · cited 1 times
PMID 42497473 · DOI 10.1016/j.schres.2026.06.025 · Reviews and meta-analyses
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
The New England journal of medicine · June 13, 2016 · Randomized controlled trial · cited 7,608 times · open access
PMID 27295427 · DOI 10.1056/nejmoa1603827 · Human clinical research
- The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.
Lancet (London, England) · November 1, 2006 · Review · cited 3,901 times
PMID 17098089 · DOI 10.1016/s0140-6736(06)69705-5 · Reviews and meta-analyses
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
The New England journal of medicine · July 1, 2015 · Randomized controlled trial · cited 2,712 times · open access
PMID 26132939 · DOI 10.1056/nejmoa1411892 · Human clinical research
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study.
Lancet (London, England) · November 20, 2015 · Randomized controlled trial · cited 2,196 times · open access
PMID 26608256 · DOI 10.1016/s0140-6736(15)00803-x · Human clinical research
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
The lancet. Diabetes & endocrinology · August 14, 2019 · Meta-analysis · cited 1,658 times · open access
PMID 31422062 · DOI 10.1016/s2213-8587(19)30249-9 · Reviews and meta-analyses
Latest publications
- Hyperglycemia promotes maladaptive Dectin-1 signaling and impairs skin antifungal host defense.
Infection and immunity · November 12, 2026 · Animal study · cited 3 times · open access
PMID 43018239 · DOI 10.1128/iai.00326-26 · Animal studies
- Excessive Intrapancreatic Fat Deposition and the Potential Therapeutic Role of Glucagon-Like Peptide-1 Receptor Agonists: A Systematic Review.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · November 10, 2026 · Systematic review · cited 0 times
PMID 43008789 · DOI 10.1055/a-2988-3090 · Reviews and meta-analyses
- Effectiveness of GLP-1 RAs and SGLT-2is for Weight Loss and Glycaemic Control: An Observational Emulation of a Target Trial.
Diabetes, obesity & metabolism · November 9, 2026 · Observational human study · cited 0 times · open access
PMID 43003406 · DOI 10.1111/dom.71515 · Human clinical research
- Psychiatric symptoms, psychological well-being and quality of life after metabolic and bariatric surgery versus incretin-based therapy in obesity: The role of weight loss.
General hospital psychiatry · November 4, 2026 · Observational human study · cited 0 times · open access
PMID 42994195 · DOI 10.1016/j.genhosppsych.2026.10.008 · Human clinical research
- GLP-1 Receptor Agonists Versus Empagliflozin or Dapagliflozin in the MASLD-Heart Failure Phenotype: An Exploratory Propensity-Matched Cohort Study.
Balkan medical journal · November 2, 2026 · Observational human study · cited 0 times · open access
PMID 42969666 · DOI 10.4274/balkanmedj.galenos.2026.2026-7-49 · Human clinical research
- The effect of glucagon-like peptide-1 receptor agonists on bone metabolism: A systematic review and meta-analysis of randomized placebo-controlled trials of predominantly first-generation agents.
Bone · November 2, 2026 · Review · cited 0 times
PMID 42971377 · DOI 10.1016/j.bone.2026.118160 · Reviews and meta-analyses
- Liraglutide and Semaglutide Induce Nitric Oxide-Dependent Contraction of Larger and Relaxation of Smaller Porcine Retinal Resistance Vessels Ex Vivo.
Investigative ophthalmology & visual science · November 1, 2026 · Animal study · cited 0 times · open access
PMID 42975103 · DOI 10.1167/iovs.67.13.7 · Animal studies
- Liraglutide Dose Affordability and Durability in Real-World Obesity Care.
Endocrinology, diabetes & metabolism · November 1, 2026 · Editorial, letter or other · cited 0 times · open access
PMID 42867112 · DOI 10.1002/edm2.70364 · Commentary and other
- Cardiovascular outcomes of glucagon-like peptide-1 receptor agonists: A systematic review.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · November 1, 2026 · Systematic review · cited 0 times · open access
PMID 42033237 · DOI 10.1093/ajhp/zxag121 · Reviews and meta-analyses
- Liraglutide in type 1 diabetes: Cardiometabolic benefits and vascular risk assessment.
Diabetic medicine : a journal of the British Diabetic Association · October 31, 2026 · Not yet classified · cited 0 times
PMID 42965922 · DOI 10.1111/dme.70524 · Not yet classified
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: Liraglutida; Liraglutide; Liraglutidum; NN2211; Saxenda; Victoza
((TITLE_ABS:"Liraglutida" OR CHEM:"Liraglutida") OR (TITLE_ABS:"Liraglutide" OR CHEM:"Liraglutide") OR (TITLE_ABS:"Liraglutidum" OR CHEM:"Liraglutidum") OR (TITLE_ABS:"NN2211" OR CHEM:"NN2211" OR TITLE_ABS:"NN 2211" OR CHEM:"NN 2211") OR (TITLE_ABS:"Saxenda" OR CHEM:"Saxenda") OR (TITLE_ABS:"Victoza" OR CHEM:"Victoza")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). Liraglutide research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/liraglutide